Bone loss seen in kids after stem cell therapy

	Tweet

A type of stem cell therapy called hematopoietic cell transplantation (HCT) often leads to a reduction in bone formation in children, according to Minneapolis-based researchers. HCT is used to treat cancers of the blood such as leukemia.

Dr. Anna Petryk and colleagues at the University of Minnesota studied the impact of HCT on bone health in 64 children aged 5 to 18 years who had undergone HCT at their institution.

“Bone mineral density (BMD) is reduced after HCT,” Petryk reported to Reuters Health.

Specifically, she and colleagues found that the proportion of children with osteopenia—a bone-thinning condition just short of osteoporosis—increased from 18 percent at baseline to 33 percent at 1 year after HCT, while the rate of full-blown osteoporosis increased from 16 percent to 19 percent.

The “absolute loss of bone mineral” corresponded to a 5.3 percent reduction in BMD at the lumbar spine, the researchers report.

Nevertheless, not all subjects were equally affected, and in some cases bone mineralization was not affected at all.

The study also shows, Petryk noted, that the level of osteocalcin, “a blood marker of bone formation, may be predictive of recovery from the initial bone loss.” Osteocalcin levels greater than 6.5 ng/L at 100 days predicted recovery from the initial bone loss at 1 year.

These findings, said Petryk, have implications for the treatment of osteoporosis in children. The medications that are typically being used in adults with osteoporosis inhibit the harmful process of bone resorption. “However, we did not find an increase in resorption in children; we found that bone formation was reduced,” she said.

“Therefore,” she concluded, “it is critical to determine in future studies whether bone resorption is increased in children or not because that will determine what treatment would be appropriate.”

SOURCE: The Journal of Clinical Endocrinology and Metabolism, March 2006. 

RELATED STORIES:
Approved lymphoma drug shows promise in early tests against bone cancer   New study shows positive role physical therapists play in lymphedema diagnois and treatment   Injured Marines at risk for abnormal bone growth   Children with cancer risk fragile bones   Leukemia risk from chlorination seen mixed   Backyard Garden May Yield Leukemia Treatment   Towards more effective treatment for multiple myeloma   Pesticides raise child risk of leukaemia   Going out on a limb   New Hope for Deadly Childhood Bone Cancer   A New Way to Build Bone   Researchers Identify Potential Therapeutic Target in Osteosarcoma   Children with bone cancer at risk for second cancer   U of M researchers look to dogs to better understand intricacies of bone cancer   Whites at greatest risk for rare bone cancer   Yeast unravels effects of chemotherapy drugs   Children with bone cancer in their arms or legs survival rate improved   Oral Drug Sets New Survival Standard for Bone Marrow Cancer   Drug Used for Advanced Cancer Could Cause Exposed Bone in Jaw   Immune-Based Drug Approved in Europe for Pediatric Cancer Patients   Freezing Bone Cancer Tumors Reduces Pain   Radical Surgery Removes Half of Pelvis, Saves Leg

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]